Effectiveness of various minimally invasive glaucoma surgical procedures

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038944

Enrollment

300

Registered

2026-02-11

Start date

2026-03-01

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H40

Interventions

Group 1: The aim of this retrospective study is to comparatively analyze the effectiveness of different minimally invasive glaucoma surgical procedures (MIGS). This study evaluates patients treated wi

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Proven glaucoma Treatment using iStent, Hydrus Microstent, ELIOS or High Frequency Deep Sclerotomy (HFDS)

Exclusion criteria

Exclusion criteria: Age under 18 years Contraindication against use of MIGS (e.g., secondary glaucoma)

Design outcomes

Primary

Measure	Time frame
The primary endpoint of the study is the reduction in intraocular pressure (IOP). This parameter is checked after one day (T1), after 10 days (T2), after 4-6 weeks (T3), and after 3 months (T4) post-operatively. The tonometry is performed using applanation.	—

Secondary

Measure	Time frame
The secondary endpoint is the reduction in the number of antiglaucoma medications.	—

Countries

Germany

Contacts

Public ContactTimo Schönfelder

Südblick GmbH

timo.schoenfelder@suedblick.de+4982141903010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026